Nobody bought a model this week: Oura takes 42 billion hours of biometrics to Nasdaq, Hinge pays $105M for two million covered lives, and the 1,700 codes UnitedHealthcare just dropped are the exact pain AI was bought to automate
Read only the cheques written this week and you get the opposite of a foundation-model arms race. On September 4 Oura filed its S-1 with the SEC, pitching not sensors but "42 billion hours of longitudinal biometric data" and five million paying members (Fierce Healthcare, 2026-09-04). The same day Thyme Care took $125M at a valuation above $2B, led by Morgan Health with Humana and CVS Health Ventures on the cap table (MobiHealthNews, 2026-09-04). The day before, Hinge Health closed an all-cash $105M purchase of Cylinder Health, buying "nearly 100 enterprise clients representing approximately two million covered lives" (HIT Consultant, 2026-09-03). Three cheques, not one of them for a better model.
On the buy side, meanwhile, the market is busy shrinking its own pain. On September 2 UnitedHealthcare said it would drop prior authorisation on roughly 1,700 service codes from October — about 30% of its preapproval requirements (Healthcare Dive, 2026-09-02) — barely a fortnight after R1 agreed to buy prior-auth automation vendor Humata Health (Fierce Healthcare, 2026-08-18). That is the pairing worth remembering today: when the reason to pay for AI is "it handles a broken process for you", the payer can delete the process from under you at any time.
01 — Top Stories
Oura files its S-1: a hardware company going public as an "AI-powered preventive health platform"
Smart-ring maker Oura filed its S-1 with the SEC on September 4, targeting Nasdaq under the ticker "OURA" after a confidential submission in May 2026. For the nine months to June 30, 2026: revenue of $1.2B, up 74% year on year from $698M, split into $974M hardware and $240.5M membership subscriptions (up 121%); net income of $60.8M, adjusted EBITDA of $107M and 55% gross margins. Five million paid members, a 94% conversion rate and 85% twelve-month retention. Trailing-twelve-month revenue is above $1.4B. Its October 2025 Series E raised $900M at roughly an $11B valuation (Fierce Healthcare, MobiHealthNews).
This is the largest public-market test digital health has had since Hinge Health, and it tests a very specific proposition: whether a wearables company can win software multiples on a "data asset plus subscription" story. The filing positions Oura as "an AI-powered health platform with recurring subscriptions, strong consumer engagement, a large proprietary data asset and a long-term opportunity in preventive healthcare", sizing a $90B-plus serviceable market against its current ~2% share of global annual wearable shipments. Hardware is still four-fifths of nine-month revenue, and that is precisely the tension the market will price.
Oura (Finland/US), the Oura Ring 5, and the Oura Advisor subscription; rivals include Whoop (which raised $575M in H1 2026, per Rock Health's tally), Samsung's Galaxy Ring and the Apple Watch ecosystem.
An S-1 is a seller's document: every market-size figure and the "AI platform" framing are the company's own language, not independently audited. Two outlets also quote gross margin differently — Fierce reports 55%, MobiHealthNews 89% — most likely blended-with-hardware versus membership-only; both are reported here rather than reconciled by guesswork. Share count and price range are still undetermined.
UnitedHealthcare drops ~1,700 prior-auth codes — the payer just deleted 30% of the pain revenue-cycle AI had been bought to solve
On September 2 UnitedHealthcare told providers it would remove prior-authorisation requirements from roughly 1,700 service codes starting October 2026 — about 30% of its total preapproval requirements. The breakdown: 800-plus codes in commercial plans, ~940 in ACA plans, ~120 across Medicare Advantage and dual special-needs plans, between three and 600-plus in Medicaid depending on the state, and 1,400 in Oxford plans across New York, New Jersey and Connecticut. Categories span oncology, cardiology, orthopaedic and musculoskeletal procedures, genetic and lab testing, chiropractic care, physical/occupational/speech therapy, home health and durable medical equipment. The insurer also widened eligibility for its national gold-card programme (Healthcare Dive, Becker's).
It only gets interesting alongside a story from August 18: R1 RCM agreed to acquire prior-auth automation vendor Humata Health and fold it into Phare OS to build "the most intelligent and integrated pre-bill architecture in the industry". Humata claims a 96% first-pass approval rate for physicians, a 30% drop in write-offs and an 83% drop in rescheduled appointments (Fierce Healthcare, R1 newsroom). The addressable market for this class of AI is exactly "the total quantity of administrative friction" — and the friction is owned by insurers, not by the people selling the automation. UNH's cut was not aimed at R1, but it demonstrates who controls the water supply to that moat. The flip side: the remaining 70% is harder, because what survives a cull like this is the complex, expensive, judgement-heavy tail.
All three Humata figures are vendor-reported and not independently audited. UNH's announcement is a provider memo; what actually lands depends on state- and plan-level detail, and the coverage makes no claim that automation or AI motivated it — the connection drawn here is editorial judgement, not either party's assertion. The R1–Humata deal value was not disclosed; it is expected to close in Q3 2026.
Hinge Health closes its $105M purchase of Cylinder: year one as a public company, spent buying covered lives
On September 3 Hinge Health completed an all-cash $105M acquisition of virtual digestive-care platform Cylinder Health. Cylinder serves nearly 100 enterprise clients covering roughly two million lives, is integrated with two of the three largest US pharmacy benefit managers, works with three of the top five commercial plans by self-insured share, and has treated more than 150,000 patients. 7wire Ventures, an investor since 2021, exits through the deal. A unified GI care programme is slated for 2027 (HIT Consultant, Hinge Health IR).
Hinge's clinical rationale is comorbidity: chronic pain, pelvic health and gut symptoms often share central-sensitisation and gut-brain-axis pathways. The commercial rationale is blunter — one in four US adults has a chronic GI condition, direct medical spending runs to $135B a year, and 69% of US counties have no practising gastroenterologist. But the real asset is distribution: a book of roughly 100 employer contracts already signed. Sword Health is running the same play this week, moving to buy Headspace all-cash per a regulatory filing, at up to $300M according to Axios, with a September 14 expected close (STAT, Axios Pro). Two companies born in musculoskeletal care, acquiring their way into multi-specialty employer platforms.
Cylinder's client and covered-lives figures come from the deal announcement and are not independently verified. The $300M ceiling on Sword/Headspace comes from Axios Pro — paywalled, and cited here only from the publicly visible headline and dek — and neither company has confirmed a figure.
Thyme Care raises $125M above a $2B valuation — and restructures itself into a holding group
On September 4 Nashville-based oncology navigation company Thyme Care announced a $125M Series E at a valuation above $2B. Morgan Health, JPMorgan's healthcare arm, led; Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health joined. It comes less than a year after a $97M Series D and an announcement of profitability. The company also formed a holding entity, Thyme Companies: co-founder Robin Shah becomes executive chairman, Brad Diephuis stays on as Thyme Care CEO and Bobby Green continues as chief medical officer and president (MobiHealthNews, 2026-09-04).
The cap table is the argument. With Morgan Health leading and Humana and CVS Health Ventures alongside, this money is buying a risk-bearing care model, not a technology licence; the holding structure signals that more oncology-adjacent businesses will be acquired into it. Worth noting: the coverage does not mention AI at all. In a year when everything is labelled AI, a $2B-valuation digital health round can still close without an AI story — which is itself a signal about where the market has matured to.
Revenue and member counts were not disclosed; the earlier profitability claim is the company's own and unaudited. The "above $2B" valuation is a band, not a precise figure.
OpenAI commits $1B to subsidise cyber models for hospitals, water utilities and local government
On September 3 OpenAI launched "Daybreak for Frontline Defenders", committing $1B in subsidised access to its Daybreak cyber models, training and technical support for resource-constrained essential-service organisations: water utilities, community banks, health systems and local governments, with public hospitals reached through a partnership with the Multi-State ISAC. There are two tiers — Daybreak Blue for routine defensive work and Daybreak Red for sensitive operations — with 35-plus enterprise products in the Daybreak Defense Network and thousands of defenders across 2,000 approved organisations already using it. The spend is expected to run over six months (Becker's Hospital Review, 2026-09-03).
This is a route into hospital IT budgets and vendor lists that has nothing to do with clinical care. What gets subsidised is security; what gets bought is trust and a deployment foothold inside critical infrastructure — in the same week OpenAI wired ChatGPT into Epic records (MobiHealthNews, 2026-09-04). The day before, Anthropic unveiled cyber safeguards shaped partly by healthcare input, putting two frontier labs in the same doorway (Becker's, 2026-09-02).
The "$1B" is a self-declared subsidy allowance with no published methodology — list-price value of discounts or actual cost is unclear — and the 2,000-organisation, thousands-of-user figures are also OpenAI's own. The healthcare share is not broken out.
Two more tooling acquisitions in the same week — each one buying an existing connection, not a capability
From Fierce Healthcare's September 4 weekly rundown: Vitality acquired digital engagement platform Icario, creating a combined reach of 19 million members across 30% of US health plans; LeanTaaS acquired care-transition platform Aidin for discharge coordination, claiming a 0.86-day reduction in length of stay and roughly $1.7M in annual savings per facility; Healwell AI signed a deployment agreement with Converge Health Iowa to push clinical search and summarisation tools across a statewide health information exchange; and Hims & Hers entered Australia via the rebranded Pilot platform, targeting $1B in international revenue within three years (Fierce Healthcare weekly rundown, 2026-09-04).
Four deals, one shape: the buyer wants a connection the target already has — a roster of health plans, a hospital discharge workflow, a statewide HIE, an existing prescribing channel in a country. Becker's named the pattern back in July, the "AI virtual-care consolidation wave": fewer deals but bigger ones, "aimed at building scaled, AI-native platforms rather than funding early-stage bets". Digital health deal volume fell to a decade low of 228 in Q2 2026, down 36% quarter on quarter, while median deal size rose 54% year to date to $7.7M (Becker's, 2026-07-31).
None of the four deal values was disclosed. LeanTaaS/Aidin's 0.86 days and $1.7M, and Vitality/Icario's 19 million members and 30% share, are all marketing figures supplied by the parties.
Mercy becomes the first system to run nurse-facing ambient AI on Android — an operating system decided who could buy
On September 3 Mercy said it had become the first health system to deploy Microsoft's nurse-facing ambient AI documentation tool on Android devices. A three-unit pilot expands to one med-surg unit at each of 12 more hospitals, with all med-surg units across its acute-care facilities targeted by June 30, 2027; Mercy runs 50-plus hospitals with about 15,000 nurses. During the pilot, flowsheet documentation time fell 22% per shift (Becker's Hospital Review, 2026-09-03).
A small story that exposes an under-discussed constraint on the ambient AI market: iOS-only support effectively excluded every Android-standardised health system from the addressable market — not because the model was weak, but because the handset was wrong. Nursing is already harder than physician documentation, because it writes into structured fields rather than narrative summaries; Abridge only made its nursing product generally available across 250-plus partner systems in May, where high-adoption nurses at Corewell Health saved about 30 minutes a shift (Newsweek, 2026-05-06). Double the eligible devices and you genuinely double the market.
The 22% comes from a three-unit pilot: small sample, no control arm, self-reported by the health system. Abridge's 30 minutes is likewise vendor- and customer-reported.
02 — Product Analysis
Oura Ring 5 + Oura Advisor
Consumer wearable subscription · Oura (Finland/US)
Function and position. The hardware is a ring; the product is a subscription. Ring 5 carries updated sensors and software designed to combine clinical history with continuously collected biometrics, and the S-1 positions the company as an "AI-powered health platform" aimed at preventive care (Fierce Healthcare). The buyer is the consumer, not a hospital or an insurer — the sharpest difference between Oura and every other company on this page.
- Strength : the data asset cannot be bought quickly with capital. 42 billion hours of longitudinal biometrics, five million paid members, 85% twelve-month retention and a 94% conversion rate took a decade to accumulate, not a funding round (S-1 figures via Fierce).
- Strength : membership revenue is growing far faster than the top line — 121% to $240.5M versus 74% overall — meaning the revenue mix is tilting toward software, which is the precondition for winning a software multiple.
- Concern : hardware is still $974M of $1.2B — roughly four-fifths of nine-month revenue — and it faces Samsung's and Apple's distribution and pricing pressure. Nothing in the public coverage of the S-1 discloses how membership retention relates to the hardware replacement cycle.
- Concern : the "$90B-plus preventive-care serviceable market" is the company's own estimate with no third-party decomposition, and the filing offers no timeline or regulatory strategy for the leap from consumer subscription to clinical or reimbursed status. That is the largest empty space in the valuation story.
Humata Health（併入 R1 Phare OS）
Prior-authorisation automation · R1 RCM (US)
Function and position. It automates the whole provider-side prior-authorisation submission with AI, and after R1's acquisition becomes part of the Phare OS pre-bill architecture — billed as "the most intelligent and integrated pre-bill architecture in the industry", with the deal expected to close in Q3 2026 (R1 newsroom). The buyer is the provider's finance office, and the reason to pay is a quantifiable cash-flow improvement.
- Strength : the ROI story is clean enough to need no clinical validation. A 96% first-pass approval rate, 30% fewer write-offs and 83% fewer rescheduled appointments all translate straight into numbers a CFO reads (Fierce Healthcare).
- Strength : the base is large. A KFF analysis found insurers denied 12–18% of standard prior-auth requests in 2025 across Medicare Advantage, Medicaid managed care and ACA marketplace plans, covering roughly 71 million enrollees.
- Concern : the serviceable market is set unilaterally by the counterparty. One UnitedHealthcare memo removed 30% of its own preapproval requirements, effective October (Healthcare Dive). If other large payers follow — and CMS interoperability rules and state legislation both push that way — this product category keeps getting thinned from upstream.
- Concern : the deal value was not disclosed and Humata's funding history is absent from the coverage, so there is no way to judge whether R1 paid a sensible price; and all three performance figures are vendor-reported, with no independent audit or peer review.
What the comparison yields. Oura's moat was grown in-house and would take a rival a decade to match, but its path to monetisation — from consumer subscription into reimbursed care — is unproven. A product like Humata proves its monetisation in a day, but its moat is held by insurers who can drain it at will. Capital paid for both in the same week, which suggests buyers have not decided which bet they are making either.
03 — Companies & Competition
| Company | Recent state & numbers | Position & moat |
|---|---|---|
| Oura Consumer wearable turning subscription platform |
Filed its S-1 on Sept 4 for Nasdaq under OURA. Nine-month revenue $1.2B (+74%), net income $60.8M, five million paid members, 85% retention; an October 2025 Series E raised $900M at roughly $11B (Fierce Healthcare, 2026-09-04). | The moat is longitudinal data consumers hand over willingly, plus subscription habit. It is thin where hardware still dominates the mix and where Samsung and Apple own distribution; the route into clinical and reimbursed status has no published timeline. |
| Hinge Health Employer-side multi-specialty digital care |
Closed a $105M all-cash purchase of Cylinder Health on Sept 3, gaining nearly 100 enterprise clients, ~2M covered lives and 150,000-plus treated patients; a unified GI programme arrives in 2027 (HIT Consultant, 2026-09-03). | The moat is the employer and PBM contract channel: each new specialty rides the same sales pipeline. The ceiling is fixed — employer benefit budgets — so multi-specialty expansion eventually fights Sword, Included Health and Omada over the same line item. |
| Sword Health MSK-born, buying its way into mental health |
A regulatory filing shows an all-cash move on Headspace, at up to $300M per Axios, with a Sept 14 expected close (STAT, 2026-08-25, Fierce Healthcare). | The same play as Hinge, run in the opposite direction: Hinge bought clinical adjacency (GI), Sword is buying brand and consumer reach (Headspace). A moat made of brand dilutes more easily than one made of contracts. |
| Thyme Care Oncology navigation, payer-funded |
Raised a $125M Series E above a $2B valuation on Sept 4, led by Morgan Health with Humana and CVS Health Ventures participating, and formed a holding company, Thyme Companies (MobiHealthNews, 2026-09-04). | The moat is risk-sharing contracts with payers, not technology. The weakness is that such contracts depend on a handful of large insurers — the concentration risk is the cap table itself. |
| R1 RCM Revenue-cycle platform consolidator |
Announced the acquisition of Humata Health on Aug 18 — value undisclosed, expected to close in Q3 2026 — folding it into Phare OS and the R37 innovation lab (R1 newsroom, 2026-08-18). | The moat is incumbent hospital contracts and deep embedding in end-to-end billing. Its most direct threat is not a competitor but payers simplifying the process themselves — UNH's 1,700 codes, effective October, are the first cut. |
| Qualified Health Enterprise AI governance for health systems |
Closed a $125M Series B in March led by NEA with Anthropic among the investors, taking total funding to $155M at a valuation between $500M and $1B; 400,000 users across customers including Emory, Jefferson Health and all eight UT System institutions (Fierce Healthcare, 2026-03-25). | The moat is the governance layer, not the model layer — what it sells is the process that lets a hospital dare to use AI. Of the 15 health systems Becker's counted signing enterprise AI deals in 2026, five went to Qualified Health (Becker's, 2026-06-03). The risk is that Epic or a cloud provider absorbs this layer natively. |
| Weave（將由 Francisco Partners 私有化） Practice-side patient engagement software |
Announced on Aug 18 that Francisco Partners will take it private for $650M, a 34% premium, with closing expected in Q4 2026 (Francisco Partners, MobiHealthNews). | Private equity is now taking mid-cap health software off the public market at a premium, which says public pricing in that band sits below what private buyers will pay. Set against Oura's filing, the same week saw one door open and another close. |
Today's competitive structure has one shape: convergence onto distribution. Rock Health's H1 2026 numbers: $7.4B raised across 244 deals, with 20 nine-figure rounds at 19 companies taking 45% of all capital, alongside 115 acquisitions in the same period. Rock Health's own read is blunt — "as foundation models improve and AI capabilities become easier to build, technical differentiation is becoming harder to sustain" (Fierce Healthcare on Rock Health's data). Once the model itself stops being the difference, the only things left to buy are: who already reaches the patient, who already signed the employer, and who is already on the hospital's approved-vendor list. Every cheque this week bought one of those three.
04 — Taiwan Angle
(1) What Taiwan is building is precisely what US buyers cannot purchase. The Executive Yuan's June 9 BTC preparatory meeting, chaired by Minister without Portfolio Wu Cheng-wen, set four pillars — AI, semiconductors, health-data integration and smart healthcare — and framed FHIR Box as "the digital foundation for nationwide medical-record interoperability". It bundles a FHIR Server, SMART Launcher and CDS Hooks, with medical centres onboarded by end-2026, regional and district hospitals by end-2027 and clinics and health centres in 2028; a first batch of 50 FHIR- and SMART-on-FHIR-compliant applications has already been published (iThome, 2026-06-09, NHIA FHIR portal). Every dollar spent in the US this week was, at bottom, a tax paid because data and distribution do not connect. If Taiwan actually finishes this substrate, it skips the tax.
(2) But be honest about the scale gap. Among the Taiwanese firms positioned to benefit from the FHIR Box build-out, Ever Fortune.AI (6841) posted H1 2026 revenue of NT$167.1M with gross margin rising from 57.8% to 73.1% and EPS of NT$0.42, holding around 57 device clearances across jurisdictions including 15 from the FDA and 24 from the TFDA; Acer Healthcare (6857) reported NT$44.65M in cumulative revenue for January–July, up 38.4% year on year; and Chunghwa Telecom (4904) is acting as systems integrator on national hospital upgrade projects (Yam News, 2026-08-24). Convert that: Ever Fortune's half-year revenue is roughly US$5.5M, while Hinge Health paid $105M cash for a single acquisition this week. The Taiwanese opening is plainly not a head-on contest but standards compatibility and international clearances — Ever Fortune's 15 FDA clearances deserve more attention than its revenue line.
(3) One concrete warning for Taiwanese buyers. The lesson worth keeping from today is UnitedHealthcare's 1,700 codes: the value of administrative automation depends on whether the process survives upstream. Taiwan's NHI review and claim-adjustment machinery sits with a single payer too, so any AI product sold on "handling NHI paperwork for the hospital" should face one question first — if the NHIA simplifies that process next year, what is left? By contrast, a deployment justified on nursing documentation time, as at Mercy with its 22% per-shift reduction in flowsheet work, does not evaporate overnight with a policy change. In Taiwanese hospitals under nursing-workforce strain, that path has a visibly better risk structure.
05 — Further Reading
-
H1 2026 funding and market overview: Durable roots, shifting routes — Rock Health (2026-07)
The denominator behind every deal today. Read it especially for the argument that technical differentiation is getting harder to sustain — that is the motive behind every acquisition in this issue.
-
State of Health AI 2026 — Bessemer Venture Partners
A venture-side taxonomy of moats. Read it against today's Oura-versus-Humata contrast and both get clearer than either does alone.
-
The AI virtual-care consolidation wave — Becker's Hospital Review (2026-07-31)
It called the shape back in July: fewer, larger deals buying distribution rather than capability. All four acquisitions in this issue land inside that frame.
-
15 health systems that have signed enterprise AI deals in 2026 — Becker's Hospital Review (2026-06-03)
A table of who actually signed with whom. For where enterprise AI procurement is really flowing, it beats any market report.
-
行政院 BTC 預備會議聚焦 AI 生技和智慧醫療，再提 FHIR Box 打造全臺病歷互通 — iThome (2026-06-09)
The most complete first-hand account of Taiwan's current smart-healthcare policy push, including FHIR Box's components and its three-phase timeline. If a Taiwanese reader reads only one piece today, this one.
06 — References
- Smart ring maker Oura files to go public, pitching investors on AI-driven preventive health. Fierce Healthcare, 2026-09-04. fiercehealthcare.com
- Oura files for IPO. MobiHealthNews, 2026-09-03. mobihealthnews.com
- Thyme Care raises $125M at over $2B valuation. MobiHealthNews, 2026-09-04. mobihealthnews.com
- Hinge Health Completes $105M Cash Acquisition of Cylinder Health. HIT Consultant, 2026-09-03. hitconsultant.net
- Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care. Hinge Health Investor Relations, 2026-08-04. ir.hingehealth.com
- Hinge Health to acquire Cylinder Health in a $105M deal to expand into gastrointestinal care. Fierce Healthcare, 2026-08-04. fiercehealthcare.com
- UnitedHealthcare cuts prior authorization from 1,700 codes. Healthcare Dive, 2026-09-02. healthcaredive.com
- UnitedHealthcare to drop prior authorization requirements for 1,700 services. Becker's Hospital Review, 2026-09. beckershospitalreview.com
- R1 acquiring Humata Health to bolster AI-powered prior authorizations. Fierce Healthcare, 2026-08-18. fiercehealthcare.com
- R1 to Acquire Humata Health, Enhancing Phare OS with AI-Powered Prior Authorization Automation. R1 RCM Newsroom, 2026-08-18. r1rcm.com
- OpenAI's $1B cyber initiative aims to protect health systems, utilities, banks. Becker's Hospital Review, 2026-09-03. beckershospitalreview.com
- Anthropic's new AI safeguards target cyberattacks with healthcare input. Becker's Hospital Review, 2026-09-02. beckershospitalreview.com
- OpenAI connects ChatGPT to Epic EHRs. MobiHealthNews, 2026-09-04. mobihealthnews.com
- Sword Health to acquire Headspace, according to filing. STAT News, 2026-08-25. statnews.com
- Sword Health to acquire Headspace in all-cash deal. Fierce Healthcare, 2026-08. fiercehealthcare.com
- Scoop: Sword Health to acquire Headspace for up to $300M. Axios Pro, 2026-08-26. axios.com
- Weekly Rundown: Vitality acquires Icario; LeanTaaS acquires Aidin; Hims expands to Australia. Fierce Healthcare, 2026-09-04. fiercehealthcare.com
- Healthcare Dealmakers—UHS closes Talkspace acquisition, Sanford's North Memorial deal clears. Fierce Healthcare, 2026-09-04. fiercehealthcare.com
- Mercy is 1st system to put ambient AI for nurses on Android. Becker's Hospital Review, 2026-09-03. beckershospitalreview.com
- Abridge Expands Nursing AI Platform to 250+ Health Systems. Newsweek, 2026-05-06. newsweek.com
- Digital health funding hits $7.4B in 2026 as AI investment reshapes the market. Fierce Healthcare, 2026-07. fiercehealthcare.com
- H1 2026 funding and market overview: Durable roots, shifting routes. Rock Health, 2026-07. rockhealth.com
- The AI virtual-care consolidation wave. Becker's Hospital Review, 2026-07-31. beckershospitalreview.com
- 15 health systems that have signed enterprise AI deals in 2026. Becker's Hospital Review, 2026-06-03. beckershospitalreview.com
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems. Fierce Healthcare, 2026-03-25. fiercehealthcare.com
- Weave Announces Acquisition by Francisco Partners. Francisco Partners, 2026-08-18. franciscopartners.com
- Weave Communications to be acquired by Francisco Partners for $650M. MobiHealthNews, 2026-08-18. mobihealthnews.com
- Health IT Business News, Financial Edition. Health IT Answers, 2026-09-03. healthitanswers.net
- Ex-Epic AI leader lands at health tech company. Becker's Hospital Review, 2026-09-01. beckershospitalreview.com
- 行政院 BTC 預備會議聚焦 AI 生技和智慧醫療，再提 FHIR Box 打造全臺病歷互通. iThome, 2026-06-09. ithome.com.tw
- 台灣醫療 AI 掀全國基建！FHIR Box 串聯跨院 長佳智能、遠傳受惠. 蕃新聞, 2026-08-24. n.yam.com
- 電子病歷（FHIR）申請專區. 衛生福利部中央健康保險署. nhi.gov.tw
- State of Health AI 2026. Bessemer Venture Partners, 2026. bvp.com